Physician

Pathology

Dr. Dhananjay A. Chitale works in the field of Pathology. He studied medicine at Seth G.S. Medical College. He received awards:"Super Doctor". Dhananjay Chitale is a published doctor and has 37 publications published. The lastest was: 'Benign metastasizing chondroblastoma: a case report.' Doctor Dhananjay A. Chitale, MD accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Methylation in Benign Prostate and Risk of Disease Progression in Men Subsequently Diagnosed with Prostate Cancer.
• Mutational landscape of aggressive prostate tumors in African American men.
• Inhibition of 5-Lipoxygenase Selectively Triggers Disruption of c-Myc Signaling in Prostate Cancer Cells.
• Anti-centrosome antibodies in breast cancer are the expression of autoimmunity.
• Intraoperative Clinical Assessment and Pressure Measurements of Sentinel Lymph Nodes in Breast Cancer.
• Precursor lesions of mucinous carcinoma of the breast: analysis of 130 cases.
• Prevalence of terminal duct lobular units and frequency of neoplastic involvement of the nipple in mastectomy.
• Adenomyoepithelioma of the breast: a brief diagnostic review.
• Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma.
• Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, Int...
• Differential expression of aurora-A kinase in T-cell lymphomas.
• Methylation of the Retinoic Acid Receptor Beta Gene Increases Risk for Prostate Cancer in African Americans.
• Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM.
• Angiolipoma of the female breast: clinicomorphological correlation of 52 cases.
• Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans.
• Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
• Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
• Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
• Intraspinal endodermal cyst: ultrastructural study of abnormal cilia.
• Admixture Fine-Mapping in African Americans Implicates XAF1 as a Possible Sarcoidosis Risk Gene.
• Systemic AL amyloidosis due to non-Hodgkin''s lymphoma: an unusual clinicopathologic association.
• Benign metastasizing chondroblastoma: a case report.
• An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
• False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 concecutive cases of missed breast cancer.
• Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.
• EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression.
• Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.
• Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.
• Genomic and biological characterization of exon 4 KRAS mutations in human cancer.
• Clinical performance of JAK2 V617F mutation detection assays in a molecular diagnostics laboratory: evaluation of screening and quantitation methods.
• The Henry Ford production system: LEAN process redesign improves service in the molecular diagnostic laboratory: a paper from the 2008 William Beaumont hospital sympos...
• The role of lymph node metastasis in the systemic dissemination of breast cancer.
• Genetic predictors of MEK dependence in non-small cell lung cancer.
• Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.
• Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women.

Schools

---

• Seth Gs Med Coll Bombay

• Henry Ford Hospital

• Memorial Sloan Kettering Cancer Center

Doctors Specialties

---

• Molecular Genetic Pathology
• Pathology

Accepted Insurances

---

Awards

---

• Super Doctor

Education

---

• Memorial Sloan-Kettering Cancer Center
• Henry Ford Hospital - Wayne State University
• Seth G.S. Medical College

Hospital

---

• Henry Ford Hospital

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1659571057
Last Name Of The Provider	CHITALE
First Name Of The Provider	DHANANJAY
View All

Similar Doctors

---

	Dr. Richard J. Zarbo, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Lamia Fathallah, MD This Doctor is OpenDoctor Recommended.
	Dr. Harish Budev, MD This Doctor is OpenDoctor Recommended.
	Dr. Ather Naseemuddin, MD This Doctor is OpenDoctor Recommended.
	Dr. Paula A. Sochacki, MD This Doctor is OpenDoctor Recommended.
	Dr. Barbara J. Anderson, MD This Doctor is OpenDoctor Recommended.
	Dr. David E. Nowak, MD
	Dr. Gaurav Sharma, MD This Doctor is OpenDoctor Recommended.
	Dr. Hana Vakil, MD This Doctor is OpenDoctor Recommended.
	Dr. Maheswari Ramineni, MD
	Meenu Sharma

---

Doctor Directory | TOS | twitter | FB | Angel | blog